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[gD Immune Complex Vasculitis in a 
Patient With Hyperimmunoglobulinemia D 
and Periodic Fever
Bart W. Boom, MD; Mohamed R. Daha, PhD; Bert-Jan Vermeer, MD, PhD; Jos W. M. van der Meer, MD, PhD
•  We describe a 27-year-old Dutch woman with the hy­
perimm unoglobulinemia D and periodic fever syndrome. 
During febrile  a ttacks she occasionally presented with  
skin lesions on the distal parts of her upper and lower ex­
tremities, w ith the h isto log ic p icture of a leukocytoc lastic  
vasculitis. Clear perivascular deposits of IgD and C3 were  
present in early lesional skin on im m unofluorescence in­
vestigation. C irculating IgD immune com plexes were dem­
onstrated on several occasions, both during and in be­
tween clin ical a ttacks. These find ings are consistent with  
an IgD immune com p lex-m ed ia ted  pathogenesis fo r the 
skin lesions. In 10 patients w ith other form s of immune 
complex vasculitis of the skin, minimal perivascular de­
posits o f IgD were found in four cases. In these cases, 
however, IgD was never found as the solitary im m unoglo­
bulin class.
{Arch D erm ato l. 1990;126:1621-1624)
Hyperimmunoglobulinemia D (hyper-IgD) and pe­riodic fever syndrome is rare but well defined. 
Since the original description by Van der Meer and 
coworkers1 in 1984, similar cases have been reported 
by others,2"’ confirming the unique nosologic entity. 
The syndrome is characterized by recurrent attacks of 
high fever (>39°C), for which no cause can be found, 
and a substantially elevated serum level of polyclonal 
IgD. The cause of this syndrome is still obscure, but 
it is possibly immune complex mediated.
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Attack rates can vary from once a month to once 
every few years. The duration of an individual attack 
ranges from 1  to 6 days. Other symptoms th a t can be 
present are headache, lymphadenopathy, abdominal 
distress, and arthralgia. The hyper-IgD syndrome 
may resemble familial m editerranean fever (FMF) in 
some respects. There are, however, some clear differ­
ences. F irs t of all, there is a difference in ethnic back­
ground. Familial m editerranean fever is almost ex­
clusively found in people of Jewish, Armenian, and 
Arabic ancestry. Second, lymphadenopathy is not a 
feature of FMF, while severe abdominal attacks th a t 
are prominent in FMF have not been observed in the 
hyper-IgD syndrome. Third, patients with FMF re­
spond rapidly to colchicine. In patients with hyper- 
IgD this response is less clear. Finally, patients with 
FMF do not have a hyper-IgD status.
In the original report, one of the patients was de­
scribed as having a painful transien t “rash ” on the 
distal parts of the extremities during a febrile a ttack .1 
An immune complex pathogenesis for these skin 
lesions was suggested, since histologic proof of vas­
culitis was found. A specific role for IgD, however, was 
not established because the authors did not investi­
gate the possibility of deposits of IgD, nor did they try  
to demonstrate IgD immune complexes in the circu­
lation.
Recent findings in the same patient indicate th a t 
these vasculitic skin lesions are indeed caused by IgD 
immune complexes.
REPORT OF A CASE
A white woman, born in 1961, experienced febrile attacks 
almost every month during the first years of her life.
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A ccom pany ing  sy m p to m s  were abdom ina l  pain, d ia r rh e a ,  
and  ly m p h ad en o p a th y .  A p a r t  f ro m  an e levated  e ry th ro c y te  
se d im e n ta t io n  ra te ,  leukocytosis, and occasional p ro te in ­
u r ia  and  e ry th ro c y tu r ia  w ith  e ry th ro c y te  ca s ts  d u r in g  
febrile  a t tacks ,  ex tensive  in v es t ig a t io n s  failed  to reveal any
I
•*.V
* r 4 -
è*' 
- V
0
Fig 1. —  Biopsy specimen of erythematous papule showing 
fibrinoid changes of vessel walls and mixed neutrophilic and 
lymphocytic perivascular infiltrate with slight leukocytoclasia 
and a few extravasated erythrocytes (hematoxylin-eosin, orig­
inal magnification X240).
u n d e r ly in g  d isorder .  In 1980 the  p a t ie n t  w as  first show n to 
have an e levated  polyclonal se ru m  IgD level (>7150 mg/L).  
D u r in g  the  last 7 y e a rs  th e  a t t a c k  r a te  h a s  d im in ished .  Also 
the  c h a ra c te r  of th e  a t t a c k s  has  changed ,  abdom ina l  pain 
and  d ia r r h e a  no longer be ing  p ro m in e n t  sym ptom s.  Now, 
p rod rom al  muscle  w eakness ,  l igh t-headedness ,  and  nasal 
congestions  a re  followed by chills  and  a su b se q u e n t  sh a rp  
rise  of body te m p e ra tu re ,  which la s ts  fo r  a p p ro x im a te ly  5 
days. Often, cervical lym ph nodes become tender .  Painfu l  
e ry th e m a to u s  m acu les  and  papu les  so m e t im es  a p p e a r  on 
th e  d is ta l  p a r t s  of h e r  e x t re m i t ie s  and  la s t  for 5 to 10 days.
Recently, the  p a t i e n t  aga in  p re sen ted  w ith  painful 
e ry th e m a to u s  papules  a ro u n d  he r  ankles.  Punch  biopsy 
spec im ens  w ere  ob ta ined  from  ear ly  lesional skin for h is to ­
logic e x am in a t io n  and  d irec t  im munofluorescence.
A bnorm al  ro u t in e  la b o ra to ry  findings d u r in g  the  a t ta c k  
included an e ry th ro cy te  se d im en ta t io n  r a te  of 55 m m /h ,  a 
leukocyte coun t  of 10.4 X 10VL, and  s l igh t  p ro te in u r ia  and 
e ry th ro c y tu r ia  w ith  some e ry th ro c y te  casts .  N orm al  find­
ings included the  hem oglobin  level; d if fe ren t ia l  cell count; 
liver and  k idney func tion  tes ts ;  CH50, C lq ,  C3, C4, and  an- 
t in u c le a r  an t ibody  levels; a n t i s t r e p to ly s in  test;  h e p a t i t i s  
serologic profile; and  to ta l  IgE  concen tra t ion .
S erum  for IgD and  for th e  d e te rm in a t io n  of im m une  
complexes w as  frozen im m e d ia te ly  a t  —70°C. S e ru m  IgD 
w as d e te rm in e d  by rad ia l  im m unodiffus ion .  A C lq  b ind ing  
assay  w as pe rfo rm ed  as described  e lsew here . '  IgD im m une  
complexes were m easu red  accord ing  to H ie m s t r a  e t  a l .19
Fig 2. —  Perivascular deposits of IgD (left) and C3 (right) in granular staining pattern (immuno­
fluorescence, original magnification X350).
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D irec t  im m unofluorescence  w as  p e r fo rm ed  on se r ia l  cry- 
o s ta t  sec tions w i th  monospecific fluorescein iso th io c y a n a te -  
conjugated  a n t i s e r a  a g a in s t  Clq and  C3 and  a g a in s t  the  
heavy ch a in s  of h u m a n  IgM, IgG, IgA, and  IgD (D akopa t t ,  
Copenhagen, D en m ark ) .  To v a l id a te  these  inves t iga t ions ,  
we in ves t iga ted  ea r ly  lesional skin f ro m  10  p a t i e n t s  w ith  
histologically proved leukocytoclastic  vascu li t is  for  the  
presence of IgD.
RESULTS
The serum IgD level was 3110 m g/L (normal, <15 
mg/L). The level of circulating IgD immune com­
plexes was 1172 m g/L during the attack and ranging 
from 265 to 989 m g/L between the attacks. The Clq 
binding assay was 53 m gEq/L (normal, <10 mgEq/L) 
during the attack, whereas no Clq binding was found 
between attacks.
Routine histologic examination of the skin speci­
men from the patient revealed endothelial cell swell­
ing, fibrinoid changes of vessel walls, and a mixed 
neutrophilic and lymphocytic perivascular infiltrate 
with slight leukocytoclasia and a few extravasated 
erythrocytes (Fig 1 ). Direct immunofluorescence 
howed granular deposits of IgD and C3 in and around 
the vessel wall of upper dermal vessels (Fig 2). Other 
immunoglobulin deposits were not found.
Four of the 10 patients with proved leukocytoclas­
tic vasculitis from other causes showed perivascular 
deposits of IgD (patients 2, 5, 8, and 9; Table 1 ). These 
deposits were minimal and seemed to coincide with 
the perivascular infiltrate. In all four cases, the 
deposits of IgD were found in combination with 
( eposits of immunoglobulins of other classes.
COMMENT
In this article we describe a patient suffering from 
the hyper-IgD and periodic fever syndrome who 
showed perivascular deposits of IgD in early vascu- 
] tic skin lesions during an attack. No other immuno­
globulin deposits were found in these lesions. This 
finding, together with the high concentration of 
serum IgD and IgD complexes, suggests an IgD 
i mmune complex nature of the attacks and of the skin 
lasions. However, it would not be correct to assume 
such a direct causal relationship without any restric- 
1 ion. Several investigators610 have shown th a t 
perivascular deposits of IgD are found in approxi­
mately 60% of the skin lesions of patients with vas­
culitis (Table 2). Our own limited study is in agree­
ment with this. The meaning of these IgD deposits in 
terms of pathogenesis, however, is not a t all clear. 
According to P arish ,7 deposits of IgD may represent 
harmless deposits in preexisting lesions. W eidner10 
does not comment on the presence of IgD, but regards
i he histotopical localization of the IgD a good mea­
sure of the age of a vasculitic lesion. An im portant 
point is th a t only one of the 50 patients who were in­
cluded in these studies showed IgD as the single im­
munoglobulin class present.8
Normally, IgD is a very minor component (less than 
1%) of total serum immunoglobulins. Although at 
present much is known of its structure, physiologic 
localization, and behavior in the immune response,
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Table 1.— Perivascular Immunoglobulin Deposits in 
Skin Biopsy Specimens From 10 Patients With
Leukocytoclastic Vasculitis*
Patient N o./  
Sex/Age, y IgG IgM IgA IgD
Associated
Diseases
1 /F/75 •  •  • + •  •  • •  •  • Rheumatoid
arthritis
2 / M / 17 •  •  • + + + Henoch-Schonlein
purpura
3/F/53 + + • •  • •  •  • Rheumatoid
arthritis
4/M/32 •  •  • + •  •  • •  •  • Wegener’s
disease?
5/M/25 + + + + Unknown
6/M/65 + + •  •  • •  •  • Rheumatoid
arthritis
7 / M / 4 3 •  •  • + •  •  • •  •  • Unknown
8 / F / 2 0 •  •  • + •  •  • + Crohn’s disease
9 / M / 7 0 + + + + Mixed cryo­
globulinemia
10/F/75 •  •  • + + •  •  • Unknown
’ Plus sign indicates present.
Table 2 .— IgD in Cutaneous Vasculitic Lesions
Source, y
No. Positive/ 
No. Tested
Type of 
Infiltrate
Cormane and Gianetti,6 
1971
1 /3 Neutrophilic
Parish/ 1972 2 /3 Neutrophilic
3 /5 Mononuclear cell
Parish,8 1973 2 /4 Neutrophilic
4 /7 Mononuclear cell
Asghar et al,9 1975 2 /2 Neutrophilic
Weidner,10 1975 9/ 12 Neutrophilic and 
others
the biological function of both membrane-bound IgD 
and serum IgD still has to be determined .11,12
Increased levels of serum IgD have been found in a 
number of apparently unrelated disorders and condi­
tions, among which are diabetes mellitus13; 
pregnancy14; cigarette smoking15; the hyper-IgE 
syndrome16; ataxia telangiectasia17; the acquired im­
munodeficiency syndrome18 and a variety of other im­
munodeficiency disorders19; certain viral, fungal, and 
recurrent bacterial infections20 22; and the hyper-IgD 
and periodic fever syndrome.1419 Until it is clear 
exactly what causes the elevation of serum IgD, it 
seems to be legitimate to differentiate the hyper-IgD 
and periodic fever syndrome from other conditions 
associated with high levels of serum IgD by its 
distinct clinical picture .19
The patient described herein had extremely high 
levels of serum IgD. It is possible th a t all kinds of an­
tigens, such as agents th a t produce (subclinical) 
infections, and vaccines generate these IgD immune 
complexes and initiate clinical attacks.
Circulating IgD immune complexes were also de­
tected in between attacks on several occasions. Since 
it was found in a recent study th a t IgD immune com­
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plexes are also present in the serum of patients with 
increased levels of IgD who are not suffering from 
periodic fever, the question whether or not these 
complexes in patients with periodic fever reflect a 
pathologic state remains to be answered .19 According 
to the Clq binding assay, circulating immune com­
plexes, possibly composed of IgG and/or IgM, were 
present concomitantly at the moment of the attack. 
An alternative explanation for this finding might be 
tha t some of the patients’ IgD immune complexes 
contain small amounts of Cl-binding IgG or IgM with 
similar specificity to antigen. These complexes may be 
detected in the Clq binding assay. However, only 
perivascular deposits of IgD and C3 and not of IgG, 
IgM, or Clq were found on direct immunofluorescence
investigation. The perivascular deposits of C3 are 
compatible with the observation th a t aggregated IgD 
at high concentrations is able to activate complement 
via the alternative pathway .23
We realize th a t we have only indirect evidence to 
substantiate the hypothesis th a t in the patient d e ­
scribed, IgD immune complexes were crucial in the 
pathogenesis of the vasculitic lesions. If IgD immune 
complex vasculitis truly exists, it may well be con­
fined to patients suffering from hyper-IgD and peri­
odic fever.
The authors  thank Gerda Roest for preparation of the manu­
script and Hans Korff for the photography.
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